Johnson & Johnson Announces Donation of Up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Democratic Republic of Congo
October 31, 2019
October 31, 2019
NEW BRUNSWICK, New Jersey, Oct. 31 -- Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, issued the following news release:
* * *
- The government of the DRC supports use of Janssen's vaccine regimen as part of expanded public health response to country's Ebola outbreak - the second-worst on record
* * *
The government of the Democratic Republic of the Congo (DRC) has decided to use the investigational Ebola vacc . . .
* * *
- The government of the DRC supports use of Janssen's vaccine regimen as part of expanded public health response to country's Ebola outbreak - the second-worst on record
* * *
The government of the Democratic Republic of the Congo (DRC) has decided to use the investigational Ebola vacc . . .